{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:55:22Z","timestamp":1772524522638,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.cllc.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T01:33:04Z","timestamp":1374715984000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Suitability of Computed Tomography-Guided Biopsy Specimens for Subtyping and Genotyping of Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"Shih-Hsin","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Li","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ting","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhung-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sey-En","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2013.06.002_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1843.2006.00909.x","article-title":"Worldwide trends in lung cancer pathology","volume":"11","author":"Gabrielson","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.cllc.2013.06.002_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PAT.0b013e328342629d","article-title":"What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements","volume":"43","author":"Cooper","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.cllc.2013.06.002_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2559.2011.03854.x","article-title":"Personalized medicine for lung cancer: new challenges for pathology","volume":"60","author":"Kerr","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.cllc.2013.06.002_bib4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1634\/theoncologist.2008-0232","article-title":"The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies","volume":"14","author":"Scagliotti","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.cllc.2013.06.002_bib6","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1200\/JCO.2004.11.022","article-title":"Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer","volume":"22","author":"Johnson","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2013.06.002_bib8","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2013.06.002_bib9","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","article-title":"Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)","volume":"29","author":"Fukuoka","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1470-2045(11)70232-7","article-title":"Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis","volume":"12","author":"Shaw","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnci\/dji055","article-title":"Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers","volume":"97","author":"Shigematsu","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2013.06.002_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1078-0432.1167.11.3","article-title":"The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers","volume":"11","author":"Tokumo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.06.002_bib15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2013.06.002_bib16","first-page":"921","article-title":"Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma","volume":"25","author":"Miyamae","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cllc.2013.06.002_bib17","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/JTO.0b013e3181c4dedb","article-title":"ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer","volume":"4","author":"Solomon","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib18","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK","volume":"27","author":"Shaw","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JOP.2010.000166","article-title":"ASCO Provisional Clinical Opinion: epidermal growth factor receptor mutation testing in practice","volume":"7","author":"Beasley","year":"2011","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.cllc.2013.06.002_bib20","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/JTO.0b013e3181f1c8de","article-title":"Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop","volume":"5","author":"Pirker","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/JTO.0b013e318227816a","article-title":"Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach","volume":"6","author":"Salto-Tellez","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2011.10.017","article-title":"The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group","volume":"76","author":"Thunnissen","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.06.002_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/JTO.0b013e3181c6ed9b","article-title":"Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5\/6, and P63, and EGFR mutation analysis","volume":"5","author":"Nicholson","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib24","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/JTO.0b013e3181b28fb9","article-title":"Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies","volume":"4","author":"Ou","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib25","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/crad.1999.0368","article-title":"CT-guided transthoracic needle biopsy of pulmonary nodules smaller than 20\u00a0mm: results with an automated 20-gauge coaxial cutting needle","volume":"55","author":"Laurent","year":"2000","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cllc.2013.06.002_bib27","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/j.ejrad.2010.09.038","article-title":"CT-guided cutting needle biopsy of lung lesions\u2013an effective procedure for adequate material and specific diagnose","volume":"80","author":"Guimaraes","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cllc.2013.06.002_bib28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1590\/S1807-59322010000900006","article-title":"Predictive complication factors for CT-guided fine needle aspiration biopsy of pulmonary lesions","volume":"65","author":"Guimaraes","year":"2010","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.cllc.2013.06.002_bib29","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1158\/1078-0432.CCR-07-1387","article-title":"Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method","volume":"13","author":"Pao","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.06.002_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jcp.53.7.537","article-title":"Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category","volume":"53","author":"Edwards","year":"2000","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cllc.2013.06.002_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/JTO.0b013e31820b86cb","article-title":"Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer","volume":"6","author":"Nizzoli","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib32","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1164\/rccm.201202-0294OC","article-title":"Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients","volume":"185","author":"Navani","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cllc.2013.06.002_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/JTO.0b013e31820517a3","article-title":"Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing","volume":"6","author":"Rekhtman","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2214\/AJR.09.2858","article-title":"Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis","volume":"194","author":"Solomon","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cllc.2013.06.002_bib35","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1078-0432.CCR-10-2277","article-title":"Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay","volume":"17","author":"Arcila","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.06.002_bib36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/02841850802294410","article-title":"Computed tomography-guided core-needle biopsy specimens demonstrate epidermal growth factor receptor mutations in patients with non-small-cell lung cancer","volume":"49","author":"Chen","year":"2008","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cllc.2013.06.002_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.lungcan.2009.04.007","article-title":"Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needle","volume":"67","author":"Cheung","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.06.002_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.06.002_bib39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/modpathol.2010.232","article-title":"Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases","volume":"24","author":"Yoshizawa","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cllc.2013.06.002_bib40","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","article-title":"The novel histologic International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival","volume":"30","author":"Warth","year":"2012","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413001307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413001307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:04:24Z","timestamp":1761505464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730413001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1525730413001307"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2013.06.002","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suitability of Computed Tomography-Guided Biopsy Specimens for Subtyping and Genotyping of Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}